This Week Health
SOAR 2024 Bluebird Leaders This Week HealthAlex's Lemonade Stand This Week Health
SUBSCRIBE NOW to receive top 7 stories daily to your inbox
<--  All Stories

23andMe’s Fall From $6 Billion to Nearly $0

February 13, 2024
23andMe, once valued at $6 billion, now risks Nasdaq delisting with valuation down 98%, under $1 stock; CEO Wojcicki's billions lost; staff reduced 25% via layoffs, subsidiary sale; company unprofitable, may exhaust cash by 2025.
Transform Healthcare - One Connection at a Time

© Copyright 2024 Health Lyrics All rights reserved